A resurgence of coronavirus cases in several countries and a new COVID-19 variant identified in the UK are boosting fears over a slew of lockdown and...
Take a deep breath, get ready, the New Year is just around the corner, and while we’re all ready to celebrate – just on principle, because...
Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, The post 5 ways digital health, and digital...
Moderna announced that Canada has authorized the use of its COVID-19 vaccine for the immunization of people aged 18 years and older. Shares closed 3.5% higher...
The Race To Save Lives: Comparing Vaccine Development Timelines Major advancements in medicine have led to a significant increase in average life expectancy, with vaccines being...
MMC Norilsk Nickel on Dec. 23 announced the closure of a smelting shop in the town of Nikel in Russia’s Murmansk region following a decision made...
Shares of Senseonics Holdings jumped 47.1% in Wednesday's extended market trading after the medical technology company raised its 4Q sales guidance by 40% to $3.5 million....
Last week, Moderna's (MRNA) Covid-19 vaccine candidate mRNA-1273 became the second approved vaccine in the U.S. after it received emergency-use authorization from the FDA. And on...
Shares of Voyager Therapeutics were down more than 10 percent in trading on Dec. 23 after the company announced the U.S. Food and Drug Administration placed a clinical...
NYC Orders Sheriffs To Track Down Travelers Defying Quarantine Order; Hospitalizations Hit New High: Live Updates Summary: NYC orders all travelers international travelers to quarantine Swedish...
GrowGeneration Corp., the largest chain of specialty hydroponic and organic garden centers in the U.S., today announced that it has acquired Southern California-based Canopy Crop Management...
Can you feel the ground moving beneath your feet? Shares of Ocugen (OCGN) skyrocketed over 800% in the past three trading sessions after the biopharmaceutical company...
The additional challenges to launching new drugs that emerged since COVID-19 upended the biopharma industry, and life as we knew it, will continue into 2021. Yet...
It has been a year dominated by the pandemic and many life sciences research projects were put on The post 2020 in review: Pharma’s progress outside...
Pfizer and German partner BioNTech have won a second order with the US government for the supply of an additional 100 million doses of their COVID-19...
Merck & Co. has signed a $356 million deal with the U.S. government to develop, manufacture, and distribute an experimental COVID-19 therapy.
→ John Maraganore is closing out the year with a surge of new hires at Alnylam just a month after lumasiran notched an FDA approval for...
Bioregnum Opinion Column by John Carroll The clock is ticking down to the year-end deadline for an FDA approval of liso-cel, and the suspense is killing...
Black people are skeptical about the new vaccines for many reasons. If public health leaders told the full story, maybe there'd be a higher chance that...
Shares of Sorrento Therapeutics spiked 8% in Wednesday’s pre-market trading after the drugmaker filed for emergency use of its COVID-19 test with the US Food and...
Amazon’s Whole Foods Market has been accused by the US Food and Drug Administration (FDA) of allegedly offering and selling “misbranded” food products, by failing to...
HeidelbergCement is reportedly exploring the potential divestment of some of its U.S. assets as the company looks to streamline its operations. Bloomberg has reported that people...
Roche has secured EU approval for Phesgo, a fixed-dose combination of its breast cancer drugs Herceptin and Perjeta The post Roche claims EU okay for Herceptin/Perjeta...
Veracyte shares jumped 11.5% on Tuesday as the company announced a new collaboration with Bayer to advance the Precision Oncology Patient Identification Program in thyroid cancer....
Spectrum Pharmaceuticals announced that the FDA has agreed to the submission of the poziotinib NDA for non-small cell lung cancer (NSCLC) in previously treated patients with...
Credit: Daniel Hanoch In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at...
These 2 Penny Stocks Are Poised for...
As the search for more potential Covid-19 treatments continues, Kiniksa Pharmaceuticals $KNSA has revealed data for a repurposed immunology candidate it says are positive. But the...
Now that two COVID vaccines have been authorized by the FDA, questions arise. Today, a physician from Indiana University School of Medicine answers five reader questions.
Pfizer and German partner BioNTech announced that the European Commission (EC) has granted a conditional marketing authorization (CMA) to use its BNT162b2 vaccine for immunization to...